Consilium Medicum

Peer-review medical journal

Editor-in-chief

Publisher

About

Professional medical multidisciplinary journal , based on the principles of evidence-based medicine. Consilium Medicum magazine has been issued since 1999.

The journal publishes national and international recommendations, reviews, lectures, original works, and clinical cases dealing with the most actual problems of the modern medicine, as well as interviews with experts within the different fields of medicine and conferences, congresses and forums reviews.

The journal is practically-oriented and publishes articles by leading clinicians who are professional in the special field of medicine in Russia, Ukraine, Belarus, and includes the high level of scientific information.

Consilium Medicum journal is the most popular journal among medical practitioners. There are 12 thematic issues per year. The journal is designed for therapeutists, pediatricians, cardiologists, endocrinologists, gastroenterologists, pulmonologists, dermatologists, obstetrician-gynecologists, urologists, nephrologists, neurologists, rheumatologists and physicians in other specialties, as well as for resident physicians, post-graduate students and senior students at medical universities.

Types of accepted articles

  • reviews, systematic reviews and meta-analysis
  • original research
  • clinical case reports and series of clinical cases
  • letters to the editor
  • hystorical articles in medicine

Research fields

  • Internal medicine
  • Endocrinology
  • Otorhinolaryngology
  • Cardiology
  • Neurology
  • Phthisiology
  • Surgery
  • Rheumatology
  • Urology
  • Pulmonology
  • Gastroenterology
  • Gerontology and geriatrics

Publication, distribution and indexation

  • Russian and English full-text articles;
  • issues publish monthly, 12 times per year;
  • no APC, Platinum Open Access
  • articles distributr under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Indexation

  • Russian Science Citation Index (elibrary.ru)
  • DOAJ
  • CrossRef
  • Google Scholar
  • WorldCat
  • Ulrich's Periodicals Directory
  • CyberLeninka

Announcements More Announcements...

 
No announcements have been published.

Current Issue

Vol 27, No 7 (2025): Women’s and men’s health

Full Issue

Articles

A brief history of the discoveries that contributed to the development of urology in the world
Simanov R.N., Amdiy R.E., Al-Shukri A.S., Mariasova A.D., Kravchenko O.Y., Khan M.S.
Abstract

This article highlights the major discoveries and trials that have contributed to the development of world urology. The reader is presented with a literature review of the dates of life of the world's greatest minds who participated in the development of medicine and urology in particular. The events during which the most significant instruments and devices leading to the advancement of science were invented are specified. The dynamics of the development of urology is described from ancient times to the present day.

Consilium Medicum. 2025;27(7):374-379
pages 374-379 views
The relationship between May-Thurner syndrome and varicocele in men: a narrative review
Vorobev V.A., Chemezov A.P., Su-Yanz K.M., Iakubov A.K.
Abstract

May-Thurner syndrome (MTS), defined by compression of the left common iliac vein, increases left gonadal-vein pressure and may underlie otherwise varicoceles. This narrative review synthesises 25 relevant publications: case reports, series, observational and interventional studieas. Pooled evidence indicates that 67–90% of men with varicocele exhibit at least 25% iliac-venous compression, and that successful iliac stenting leads to regression of varicocele symptoms and improved fertility. The diagnostic value of combining duplex ultrasound with computed tomographic/magnetic resonance venography is highlighted, whereas catheter venography with intravascular ultrasound remains the reference for confirming haemodynamic significance. Gaps in data regarding long-term stent patency and the epidemiology of MTS in asymptomatic males have been identified. It advocates systematic iliac-vein assessment in men presenting with recurrent or bilateral varicocele and calls for prospective multicentre trials comparing surgical ligation with endovascular correction.

Consilium Medicum. 2025;27(7):380-384
pages 380-384 views
Prostate and seminal vesicle solitary fibrous tumor combined with prostate adenocarcinoma. Case report
Trushkin R.N., Ognerubov N.A., Sokolov S.А., Isaev T.K., Berezhnaya E.E., Sokolov A.A.
Abstract

Solitary fibrous tumor is an extremely rare fibroplastic mesenchymal neoplasm with an uncertain malignant potential and intermediate biological behavior. It is most often localized in the pleura. Extrapleural lesions of the genitourinary system, including the prostate gland and especially the seminal vesicles, occur in anecdotal cases. There are no specific clinical manifestations of tumor localized in the prostate gland; it can mimic prostate adenoma with infravesical obstruction. With the localization of the tumor in the seminal vesicles, local symptoms are more common: hematuria, dysuria, and hemospermia. The basis of medical imaging is contrast-enhanced magnetic resonance imaging and combined positron emission and X-ray computed tomography with various tracers. To confirm the diagnosis, a biopsy followed by histological and immunohistochemical examination with determination of CD34 and STAT6 expression in the tumor tissue is required. The main therapy for a solitary fibrous tumor is surgical excision with a resection margin of 1–2 cm. The article presents a unique clinical case of a primary multiple synchronous solitary fibrous tumor of the prostate and seminal vesicle combined with prostate cancer. This is the first such case described in the available Russian and international literature. Timely diagnosis of these neoplasms enables a rational approach to personalized treatment.

Consilium Medicum. 2025;27(7):385-390
pages 385-390 views
Comparison of transrectal and transperineal prostate biopsy: a prospective comparative study
Vorobev V.A., Akperov G.R., Baklanova O.V., Mickevich D.S., Kovalev E.V., Popov I.P., Azizov Z.S.
Abstract

Background. Transrectal (TR) prostate biopsy remains the ”gold standard” but is associated with infectious risks; transperineal (TP) biopsy is considered a safer alternative with comparable diagnostic accuracy.

Objective. To compare the diagnostic performance, complication rates, pain levels, and short-term outcomes of TR- and TP-guided prostate biopsies.

Materials and methods. A prospective randomized study included 68 men aged ≥40 years with suspected prostate cancer (PSA>4 ng/mL, positive DRE, and/or PIRADS≥3). Patients were randomized into the TP group (n=53) and the TR group (n=15). A 12-core transrectal ultrasound-guided biopsy was performed with targeted sampling of PIRADS 3–5 lesions. Overall and clinically significant cancer detection rates (Gleason score ≥7), complications (Clavien–Dindo classification), pain using the Visual Analog Scale (VAS), and events within 30 days were analyzed; p<0.05 was considered statistically significant.

Results. Prostate cancer was detected in 72.1% of patients: 75.5% in the TP group and 60.0% in the TR group (p=0.62). Clinically significant cancer accounted for 59.2% of cases (45.3% in TP vs 33.3% in TR; p=0.59). No Clavien grade III or higher complications or cases of urosepsis were observed. Minor complications occurred in 32.1% of TP and 40.0% of TR patients (p=0.69); low-grade fever requiring oral antibiotics (Clavien grade II) was reported only in 3.8% of TP cases. The procedure duration was longer for TP (20.6±5.2 min vs 10.3±3.8 min; p<0.001) but was associated with lower pain scores (2.6±1.1 points vs 4.7±1.5 points; p<0.01); 81% of TP patients rated the pain as minimal. No delayed complications were reported at 30-day follow-up.

Conclusion. Transperineal biopsy provides comparable detection of clinically significant prostate cancer, results in less procedural pain, and demonstrates an absence of severe complications, offering a safe alternative to the TR approach, particularly for patients with a higher risk of infection or difficult-to-access magnetic resonance imaging lesions.

Consilium Medicum. 2025;27(7):391-397
pages 391-397 views
CT perfusion in the diagnosis of pyelonephritis: advantages and disadvantages. A review
Pavlov V.c., Vorobev V.A., Ananiev V.A.
Abstract

Acute suppurative pyelonephritis is a severe kidney infection characterized by areas of ischemia and necrosis, making accurate assessment of renal perfusion crucial for diagnosis and treatment. In recent years, modern functional imaging techniques, including perfusion computed tomography (CT perfusion), have been increasingly used to evaluate renal blood flow. This review presents current data on the capabilities of renal CT perfusion in diagnosing and monitoring acute suppurative pyelonephritis, describing the principles of the technique and data post-processing for quantitative hemodynamic measurements. The CT perfusion method helps identify ischemic areas in the affected kidney and provides an objective assessment of perfusion impairment. Clinical studies show that perfusion abnormalities correlate with disease severity and the occurrence of suppurative complications, supporting the use of CT perfusion as an important prognostic tool for selecting optimal conservative or surgical treatment. Several advantages of CT perfusion are highlighted, such as high diagnostic value due to combined morphological and functional assessment, short examination time, and the ability to simultaneously assess both kidneys for comparison. However, the method also has significant limitations: high radiation exposure and the need for intravenous contrast increase the risk of complications (e.g., contrast-induced nephropathy) and restrict its use in patients with renal insufficiency. To mitigate these risks, careful patient selection, minimal necessary doses of radiation and contrast, and adequate hydration are recommended. Thus, renal CT perfusion is a promising adjunct in the diagnosis of acute pyelonephritis, capable of improving the assessment of pathological changes and patient outcomes when used judiciously.

Consilium Medicum. 2025;27(7):398-402
pages 398-402 views
Molecular genetic predictors of pelvic organ prolapse in women of reproductive age
Iuminova A.V., Mikhelson A.A., Semenov Y.A., Lazukina M.V., Tretyakova T.B.
Abstract

Background. Pelvic organ prolapse (POP) is a pathology that significantly affects the health and social life of women of reproductive age. According to research, 25–30% of women worldwide experience symptoms associated with POP. Many of them do not have obstetric or somatic risk factors, but POP is detected. This indicates the realization of a genetic predisposition in the formation of mental health in young women.

Aim. To identify molecular genetic predictors of POP in patients of reproductive age.

Materials and methods. A comparative study was conducted, which included 119 women of reproductive age. The first group (n=89) included patients with PT, the second group (n=30), the "control" group, – women without POP. All patients underwent polymorphism typing of genes encoding proteins involved in the formation of connective tissue (COL1A1:-1997 C>A [rs1107946], COL1A1:1546 G>T [rs1800012]), estrogen receptor genes (ESR1:-397 T>C [rs2234693], ESR1:-351 A>G [rs9340799]). Statistical processing was performed using Microsoft Excel (version 16.53, 2021), SPP Statistics 22.0, Statistica for Windows 10 (TIBCO Software Inc., Palo Alto, CA, USA), StatTech v. 4.8.3 (Stattech LLC, Russia).

Results. The polymorphism of the genes ESR1:-351-GG and COL1A1:1546-GT+TT is a predictor of the development of POP in patients of reproductive age. While the AG and AA genotypes in the ESR1:-351 and GG genes in COL1A1:1546 have a protective role in relation to the risk of developing PT.

Conclusions. Disorders in the expression or polymorphism of connective tissue genes and estrogen receptors can lead to a weakening of supportive structures and the development of genital prolapse in women of reproductive age. It is necessary to continue research aimed at studying the genetic aspects of PT for a deep understanding of the mechanisms of development of this pathology and the creation of personalized treatment tactics for patients.

Consilium Medicum. 2025;27(7):403-408
pages 403-408 views
Morphological changes in the placenta as an indicator of the effectiveness of preventive measures in pregnant women with a high risk of fetal growth restriction
Kuneshko N.F., Ershov A.V., Dobrokhotova Y.E., Lazarchuk A.V.
Abstract

Background. Many of the factors that influence placental formation are modifiable and can be corrected by pre-conception care, which plays an important role in the prevention of placental insufficiency.

Aim. To assess the effectiveness of pre-conception care and treatment and preventive measures in women at high risk of placental insufficiency and fetal growth restriction based on a pathomorphological study of the placenta.

Materials and methods. An analysis of 733 pregnancy and birth histories was performed, including ultrasound protocols and conclusion of the results of pathological and histological examination of the placentas. Five groups were identified: A (n=87) pre-conception care was carried out, B (n=195) were admitted for observation for a period of 8–16 weeks, C (n=191) – for a period of 16–24 weeks, D (n=148) – after 25 weeks in the absence of therapeutic and preventive measures earlier. Control group included 112 healthy pregnant women.

Results. The most pronounced pathological changes were in the placenta of women of group G. In women of group A, changes in the placenta were comparable to those in the control group, which indicates the success of the measures taken in the prevention of placental insufficiency. In women of subgroup B timely correction of abnormalities and risk factors also contributed to the favorable pathomorphological and functional state of the placenta and the favorable course and outcome of pregnancy.

Conclusion. The study demonstrated that pre-conception care and early preventive measures in women at high risk of fetal growth restriction significantly reduce the frequency and severity of pathological placental changes, promoting favorable pregnancy outcomes. The most pronounced abnormalities were observed in women who started prenatal care in the later stages, highlighting the importance of early diagnosis and individualized pregnancy management.

Consilium Medicum. 2025;27(7):409-414
pages 409-414 views
Immunological aspects of polycystic ovary syndrome: A review
Kandrashlina Y.A., Orlova E.A., Shtakh A.F.
Abstract

Polycystic ovary syndrome (PCOS) is a fairly common pathology that is a pressing problem because it is characterized by persistent menstrual irregularities and, as a result, leads to infertility. The aim of the study is to provide an in-depth review and analysis of existing knowledge, research and scientific literature on the role of the immune system in the development of PCOS. Impaired immune regulation in women with PCOS contributes to the development of chronic inflammation. In patients with PCOS, oocyte development is blocked as a result of the formation of chronic mild inflammation in the ovaries. The progression of this inflammatory process causes mitochondrial dysfunction, resulting in changes in the quality of oocytes, which affects ovulation. PCOS is accompanied by an increase in the levels of interleukins (IL)-1β, 6, 10 and 18 in the blood serum. In in vitro fertilization programs, a negative prognosis is noted with low levels of IL-8 and 6. In PCOS, there is mild chronic inflammation in the ovarian tissues, which leads to impaired follicle maturation. Cytokine imbalance in PCOS can be the cause of a negative outcome of in vitro fertilization. Further study of the role of the immune system in PCOS and development of immunological markers may contribute to improvement of diagnostic and treatment methods.

Consilium Medicum. 2025;27(7):415-418
pages 415-418 views